Assuming major is required, the following results were found.

  • #ECTRIMS2019 – Tysabri During Pregnancy and After Delivery Seems Safe, Reduces Relapse Risk, Study Finds

    the last dose pre-delivery. Prior studies suggested that Tysabri use over the first trimester of pregnancy is not tied to major fetal risks. However, the medicine can be found in the blood of newborns, and they commonly have blood alterations,...

    https://mschristian.org/index.php/blog/ectrims2019-tysabri-during-pregnancy-and-after-delivery-seems-safe-reduces-relapse-risk-study-finds
  • Multiple Sclerosis Drugs Market 2019| Recent Trends, In-depth Analysis, Market Size Research Report Forecast up to 2026 | Research Industry US - News Obtain

    services, hence driving the revenue growth and profitability. The research report provides a detailed analysis of all the major factors impacting the market on a global and regional scale, including drivers, constraints, threats, challenges,...

    https://mschristian.org/index.php/blog/multiple-sclerosis-drugs-market-2019-recent-trends-in-depth-analysis-market-size-research-report-forecast-up-to-2026-research-industry-us-news-obtain
  • Mechanism controlling multiple sclerosis risk identified

    genetically predisposed individuals. Researchers at Karolinska Institutet in Sweden have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a...

    https://mschristian.org/index.php/blog/mechanism-controlling-multiple-sclerosis-risk-identified
  • Blue Cross Blue Shield Association Reports Americans with Multiple Sclerosis are Three Times More Likely to Have Behavioral Health Conditions - BioSpace

    insured Americans with Multiple Sclerosis (MS) are three times more likely to have behavioral health conditions, including major depression and substance use disorder, than the overall population, according to a new Blue Cross Blue Shield Association...

    https://mschristian.org/index.php/blog/blue-cross-blue-shield-association-reports-americans-with-multiple-sclerosis-are-three-times-more-likely-to-have-behavioral-health-conditions-biospace
  • Aubagio (teriflunomide)

    take Aubagio to check your liver.Risk of birth defects. If you're pregnant, you shouldn't take Aubagio because it may cause major birth defects. If you might become pregnant and aren't using reliable birth control, you shouldn't take Aubagio. If you...

    https://mschristian.org/index.php/blog/aubagio-teriflunomide
  • The $432B Medical Devices Market: Worldwide Trends, Forecasts and Competitive Analyses (2014-2025) - P&T Community

    model. The future of the medical device market looks good with opportunities in the hospital and homecare sectors. The major drivers for market growth are increasing healthcare expenditure, technological development, growing aging population, and...

    https://mschristian.org/index.php/blog/the-432b-medical-devices-market-worldwide-trends-forecasts-and-competitive-analyses-2014-2025-p-t-community
  • Primary Progressive Multiple Sclerosis Treatment Market Studied by 2019-2027 with Profiling Player - Market Research Sheets

    market situation between consumer and supplier. Download PDF Brochure @ https://www.worldwidemarketreports.com/sample/272000 Major players operating in the Global Primary Progressive Multiple Sclerosis Treatment market include: F. Hoffmann-La Roche...

    https://mschristian.org/index.php/blog/primary-progressive-multiple-sclerosis-treatment-market-studied-by-2019-2027-with-profiling-player-market-research-sheets
  • Global Wearable Adhesive Market Growth, Trends, and Forecast Report 2019-2024 - ResearchAndMarkets.com - Business Wire

    products is rapidly increasing owing to the presence of a significant number of players in this region is also one of the major factor which is expected to act as a driver for market growth. With the growing healthcare expenditure coupled with the...

    https://mschristian.org/index.php/blog/global-wearable-adhesive-market-growth-trends-and-forecast-report-2019-2024-researchandmarkets-com-business-wire
  • With Bristol-Myers CVR, Investors Can Bet on 3 Drugs in Celgene’s Pipeline - Barron's

    first quarter of 2021. The CVRs are being issued as a bonus to Celgene shareholders by Bristol-Myers to compensate them if major drugs in the Celgene pipeline get approved and Bristol-Myers derives significant financial benefit. The CVR was changing...

    https://mschristian.org/index.php/blog/with-bristol-myers-cvr-investors-can-bet-on-3-drugs-in-celgene-s-pipeline-barron-s
  • New immunotherapy targeting blood-clotting protein

    interfering with the part of the protein responsible for clotting. "We have developed a monoclonal antibody to target a major culprit in the blood that damages the brain," said Akassoglou, who is also a professor in the Department of Neurology at UC San...

    https://mschristian.org/index.php/blog/new-immunotherapy-targeting-blood-clotting-protein
  • Despite Intense Public, Congressional Scrutiny, Pharma Still Hikes Prices For Hundreds Of Drugs In 2020 - Kaiser Health News

    at pharmacies. (Karlin-Smith, 1/2) This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription. Original link “The more things change, the more they stay the same,” Piper...

    https://mschristian.org/index.php/blog/despite-intense-public-congressional-scrutiny-pharma-still-hikes-prices-for-hundreds-of-drugs-in-2020-kaiser-health-news
  • 10 Worst-Performing Stocks of 2019 - Motley Fool

    The stock market continued its bull run this year, with all the major indexes on track to end 2019 with double-digit gains. Stocks are setting new highs despite warnings of a looming recession. The S&P 500 set 19 new all-time highs in 2019, and that's...

    https://mschristian.org/index.php/blog/10-worst-performing-stocks-of-2019-motley-fool
  • Suing Device Firms; Does AI Promote Bias? Opioid Salesman Tells All

    and gender bias ~ Addressing Bias in Artificial Intelligence in Health Care (JAMA)The Lower Drug Costs Now Act signals "a major departure" for how the U.S. plans to regulate drug prices, Stacie B. Dusetzina, PhD, and Jonathan Oberlander, PhD, write ~...

    https://mschristian.org/index.php/blog/suing-device-firms-does-ai-promote-bias-opioid-salesman-tells-all
  • Money Management in Multiple Sclerosis: The Role of Cognitive, Motor, and Affective Factors

    and low depressive symptomatology predicted efficient money management. Conclusions: This study characterizes some of the major problems and underlying impairments persons with MS are encountering in money management. Practitioners working with persons...

    https://mschristian.org/index.php/blog/money-management-in-multiple-sclerosis-the-role-of-cognitive-motor-and-affective-factors
  • How the gut influences neurologic disease

    them to develop new therapies." The new research focuses on the influence of gut microbes on two types of cells that play a major role in the central nervous system: microglia and astrocytes. Microglia are an integral part of the body's immune system,...

    https://mschristian.org/index.php/blog/how-the-gut-influences-neurologic-disease
  • Rethinking neurodegenerative disease treatment: Target multiple pathological proteins

    Nearly all major neurodegenerative diseases -- from Alzheimer's to Parkinson's -- are defined and diagnosed by the presence of one of four proteins that have gone rogue: tau, amyloid-beta (Aβ), alpha-synuclein (α-syn), or TDP-43. As such,...

    https://mschristian.org/index.php/blog/rethinking-neurodegenerative-disease-treatment-target-multiple-pathological-proteins
  • Why You Should Tell Your Neurologist If You Feel Depressed

    October 2019 While an estimated 17.3 million (or 7.1 percent of) adults in the United States have had at least one major depressive episode, we know the incidence is much higher in people with certain neurologic conditions. Poststroke depression, for...

    https://mschristian.org/index.php/blog/why-you-should-tell-your-neurologist-if-you-feel-depressed
  • Sanofi and Happify Health solidify collaboration around prescription DTx designed to address mental health in people with MS

    with MS also experience mental health conditions — particularly depression and anxiety. People with MS develop a form of major depression at a rate two to five times higher than the general population, depending on the country studied. “Many patients...

    https://mschristian.org/index.php/blog/sanofi-and-happify-health-solidify-collaboration-around-prescription-dtx-designed-to-address-mental-health-in-people-with-ms
  • Arthritis group offers first guidelines for patients who use CBD for joint pain

    guidelines for people who want to try CBD — the first such guidance on using the cannabis-derived ingredient from any major patient advocacy group. The recommendations are an attempt to provide some kind of clarity for CBD usage, despite a lack of...

    https://mschristian.org/index.php/blog/arthritis-group-offers-first-guidelines-for-patients-who-use-cbd-for-joint-pain
  • Cannabis-based drug in combination with other anti-spasticity

    from the cannabis sativa plant given as an add-on treatment may help ease symptoms of spasticity (tight or stiff muscles), a major cause of disability and reduced quality of life in people with motor neuron disease, according to a phase 2 trial of 60...

    https://mschristian.org/index.php/blog/cannabis-based-drug-in-combination-with-other-anti-spasticity

Results 1 - 20 of 42
 
 

Follow Us on Twitter

Follow Us On Twitter - Image